Pro Share Advisors LLC Trevena Inc Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.2 - $0.5 $6,132 - $15,330	-30,661 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.41 - $0.63 $2,076 - $3,190	-5,064 Reduced 14.17%	30,661 $17,000
Q4 2021 Feb 08, 2022	BUY	$0.57 - $1.29 $8,417 - $19,050	14,768 Added 70.47%	35,725 $20,000
Q3 2021 Nov 12, 2021	SELL	$1.11 - $1.7 $23,830 - $36,497	-21,469 Reduced 50.6%	20,957 $26,000
Q2 2021 Aug 13, 2021	BUY	$1.46 - $2.25 $61,941 - $95,458	42,426 New	42,426 $72,000
Q4 2017 Feb 14, 2018	SELL	$1.4 - $2.6 $52,466 - $97,437	-37,476 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.22 - $2.79 $6,016 - $7,560	2,710 Added 7.79%	37,476 $96,000
Q2 2017 Aug 11, 2017	BUY	N/A	34,766	34,766 $80,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.